ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Luvit123
|
252 |
104K |
13 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
252
|
104K
|
13
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical advances Australian clinical pilot with I-MED
|
|
Luvit123
|
48 |
15K |
8 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
48
|
15K
|
8
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY21 Results Presentation
|
|
Luvit123
|
120 |
41K |
10 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
120
|
41K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY21 Results Presentation
|
|
Luvit123
|
120 |
41K |
22 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
120
|
41K
|
22
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
8 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
5 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
3 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 LODGES SPP AND OPTIONS PROSPECTUS
|
|
Luvit123
|
104 |
40K |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
104
|
40K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 LODGES SPP AND OPTIONS PROSPECTUS
|
|
Luvit123
|
104 |
40K |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
104
|
40K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test
|
|
Luvit123
|
14 |
5.5K |
9 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
14
|
5.5K
|
9
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Luvit123
|
2.5K |
1.1M |
7 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
2.5K
|
1.1M
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C & Quarterly Activities Report
|
|
Luvit123
|
48 |
16K |
17 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
48
|
16K
|
17
|
|
ASX - By Stock
|
IIQ |
Re:
BD1 Clinical Efficacy and Valuation Discussion
|
|
Luvit123
|
16 |
10K |
9 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
16
|
10K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
BD1 Clinical Efficacy and Valuation Discussion
|
|
Luvit123
|
16 |
10K |
10 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
16
|
10K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
What are we waiting for?
|
|
Luvit123
|
26 |
10K |
2 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
26
|
10K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
What are we waiting for?
|
|
Luvit123
|
26 |
10K |
4 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
What are we waiting for?
|
|
Luvit123
|
26 |
10K |
11 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
26
|
10K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Luvit123
|
60 |
25K |
4 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
60
|
25K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Luvit123
|
60 |
25K |
3 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
60
|
25K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Luvit123
|
60 |
25K |
12 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
60
|
25K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Just Out.
|
|
Luvit123
|
60 |
25K |
13 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
60
|
25K
|
13
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Launches its RUO EXO-NET Product
|
|
Luvit123
|
53 |
22K |
9 |
16/06/21 |
16/06/21 |
ASX - By Stock
|
53
|
22K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Luvit123
|
1.4K |
554K |
5 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
1.4K
|
554K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Luvit123
|
1.4K |
554K |
4 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.4K
|
554K
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical partners with RCI for clinical pilot program
|
|
Luvit123
|
57 |
22K |
11 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
57
|
22K
|
11
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
That be great thanks
|
|
Luvit123
|
51 |
20K |
15 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
51
|
20K
|
15
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Luvit123
|
306 |
144K |
18 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
306
|
144K
|
18
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
Luvit123
|
1.4K |
554K |
11 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
1.4K
|
554K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical partners with RCI for clinical pilot program
|
|
Luvit123
|
57 |
22K |
7 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
57
|
22K
|
7
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Griffith university CEO phone call
|
|
Luvit123
|
34 |
13K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
34
|
13K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Signs Option Agreement for Type 3C Diabetes Test
|
|
Luvit123
|
84 |
29K |
4 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
84
|
29K
|
4
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Luvit123
|
306 |
144K |
43 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
306
|
144K
|
43
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical to present at NWR virtual investor conference
|
|
Luvit123
|
41 |
16K |
4 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
41
|
16K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive Results Evaluation of EXO-NET in Pancreatic Cancer
|
|
Luvit123
|
146 |
51K |
11 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
146
|
51K
|
11
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Luvit123
|
306 |
144K |
1 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
306
|
144K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
From RAC chat about Bard1, explains Merchants involvement
|
|
Luvit123
|
5 |
4.0K |
7 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
5
|
4.0K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Change in substantial holding
|
|
Luvit123
|
53 |
20K |
15 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
53
|
20K
|
15
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Luvit123
|
133 |
53K |
0 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Luvit123
|
133 |
53K |
5 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Luvit123
|
133 |
53K |
5 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Luvit123
|
133 |
53K |
10 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
10
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Alan Kohler Eureka Article & Audio
|
|
Luvit123
|
64 |
21K |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
64
|
21K
|
2
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Alan Kohler Eureka Article & Audio
|
|
Luvit123
|
64 |
21K |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
64
|
21K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
Luvit123
|
252 |
104K |
14 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
252
|
104K
|
14
|
|
ASX - By Stock
|
IIQ Medicine |
Re:
BD1 Pipeline
|
|
Luvit123
|
3 |
3.3K |
22 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
3
|
3.3K
|
22
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Becoming a substantial holder
|
|
Luvit123
|
45 |
14K |
4 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
45
|
14K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
Luvit123
|
532 |
174K |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
532
|
174K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: AGM & CEO Presentations and Chairman's Transcript
|
|
Luvit123
|
9 |
5.6K |
5 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
9
|
5.6K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
RAC Upside - promising forgotten cancer drug that works
|
|
Luvit123
|
208 |
99K |
1 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
208
|
99K
|
1
|
|